SCHEMBL20174247

SCHEMBL20174247

c1ccc(-c2cc(-c3cccc4c3-c3oc5ccccc5c3C43c4ccccc4-c4ccccc43)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.34
KMT2A Q03164 6/20 0.33
MAPK1 P28482 3/20 0.33
MEN1 O00255 5/20 0.32
MAPT P10636 3/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
HPGD P15428 3/20 0.32
ALDH1A1 P00352 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP3A4 P08684 3/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 2/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
TP53 P04637 2/20 0.32
ABCB1 P08183 2/20 0.32
AR P10275 2/20 0.32
CYP1B1 Q16678 2/20 0.32
CA9 Q16790 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174232 0.93 PDK2 (0.33) ADORA3KMT2AMAPK1MEN1MAPT
SCHEMBL20174213 0.90 KMT2A (0.33) KMT2AMAPK1MEN1MAPTL3MBTL1
SCHEMBL20174263 0.89 KMT2A (0.36) ADORA3KMT2AMAPK1MEN1MAPT
SCHEMBL20174301 0.89 ACACA (0.38) MAPK1MAPTL3MBTL1HPGDALDH1A1
SCHEMBL20174212 0.89 KMT2A (0.33) KMT2AMAPK1MEN1MAPTL3MBTL1
SCHEMBL22326546 0.87 PDK2 (0.33) PLA2G2APLA2G4APDK2
SCHEMBL20174206 0.86 MAPT (0.35) KMT2AMAPK1MEN1MAPTL3MBTL1
SCHEMBL20174283 0.85 CA1 (0.35) ADORA3KMT2AMAPK1MEN1MAPT
SCHEMBL20174275 0.85 KMT2A (0.32) KMT2AMAPK1MEN1MAPTHPGD
SCHEMBL20174231 0.85 MAPT (0.34) ADORA3KMT2AMAPK1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG ADORA3 4030/4885KMT2A 1480/4885MAPK1 3742/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG ADORA3 4030/4885KMT2A 1480/4885MAPK1 3742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.